Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol demonstrates a unique mouse model of asphyxia cardiac arrest that does not require chest compression for resuscitation. This model is useful for monitoring and imaging the dynamics of brain physiology during cardiac arrest and resuscitation.

Abstract

Most cardiac arrest (CA) survivors experience varying degrees of neurologic deficits. To understand the mechanisms that underpin CA-induced brain injury and, subsequently, develop effective treatments, experimental CA research is essential. To this end, a few mouse CA models have been established. In most of these models, the mice are placed in the supine position in order to perform chest compression for cardiopulmonary resuscitation (CPR). However, this resuscitation procedure makes the real-time imaging/monitoring of brain physiology during CA and resuscitation challenging. To obtain such critical knowledge, the present protocol presents a mouse asphyxia CA model that does not require the chest compression CPR step. This model allows for the study of dynamic changes in blood flow, vascular structure, electrical potentials, and brain tissue oxygen from the pre-CA baseline to early post-CA reperfusion. Importantly, this model applies to aged mice. Thus, this mouse CA model is expected to be a critical tool for deciphering the impact of CA on brain physiology.

Introduction

Cardiac arrest (CA) remains a global public health crisis1. More than 356,000 out-of-hospital and 290,000 in-hospital CA cases are reported annually in the US alone, and most CA victims are over 60 years old. Notably, post-CA neurologic impairments are common among survivors, and these represent a major challenge for CA management2,3,4,5. To understand post-CA brain pathologic changes and their effects on neurologic outcomes, various neurophysiologic monitoring and brain tissue monitoring techniques have been applied in patients6,7,8,9,10,11,12. Using near-infrared spectroscopy, real-time brain monitoring has also been performed in CA rats to predict neurologic outcomes13.

However, in murine CA models, such an imaging approach has been complicated by the need for chest compressions to restore spontaneous circulation, which always entails substantial physical motion and, thus, hinders delicate imaging procedures. Moreover, CA models are normally performed with mice in a supine position, whereas the mice must be turned to the prone position for many brain imaging modalities. Thus, a mouse model with minimal body movement during the surgery is required in many cases in order to perform real-time imaging/monitoring of the brain during the whole CA procedure, spanning from pre-CA to post-resuscitation.

Previously, Zhang et al. reported a mouse CA model that could be useful for brain imaging14. In their model, CA was induced by bolus injections of vecuronium and esmolol followed by the cessation of mechanical ventilation. They showed that after 5 min of CA, resuscitation could be achieved by infusing a resuscitation mixture. Notably, however, circulatory arrest in their model occurred only about 10 s after the esmolol injection. Thus, this model does not recapitulate the progression of asphyxia-induced CA in patients, including hypercapnia and tissue hypoxia during the prearrest period.

The overall goal of the current surgical procedure is to model clinical asphyxia CA in mice followed by resuscitation without chest compressions. This CA model, therefore, allows the use of complex imaging techniques to study brain physiology in mice15.

Protocol

All the procedures described here were conducted in accordance with the National Institutes of Health (NIH) guidelines for the care and use of animals in research, and the protocol was approved by the Duke Institute of Animal Care and Use Committee (IACUC). C57BL/6 male and female mice aged 8-10 weeks old were used for the present study.

1. Surgical preparation

  1. Weigh a mouse on a digital scale, and place it into a 4 in x 4 in x 7 in plexiglass anesthesia induction box.
  2. Adjust the anesthesia vaporizer to 5% isoflurane, the oxygen flow meter to 30, and the nitrogen flow meter to 70 (see Table of Materials).
  3. Take the animal out of the induction box, and lay it in a supine position on the surgical bench when its respiratory rate has decreased to 30-40 breaths per minute.
  4. Pull out the tongue with blunt forceps, and hold it using the non-dominant hand. Use the dominant hand to insert a laryngoscope (see Table of Materials) into the mouse's mouth and visualize the vocal cord.
  5. Use the non-dominant hand to insert a guide wire and 20 G intravenous catheter into the mouth. Gently insert the guide wire into the trachea.
  6. Push the catheter into the trachea until the wing part of the catheter is even with the nose tip.
    NOTE: Do not intubate a mouse that is not fully anesthetized since this may injure the trachea and cause airway bleeding.
  7. Connect the intubated mouse to a small animal ventilator (see Table of Materials), and reduce the isoflurane to 1.5%.
  8. Input the mouse's body weight into the control panel of the ventilator to determine the tidal volume and respiratory rate.
  9. Keep the mouse in a supine position under a heat lamp, and maintain the rectal temperature at 37 °C with a temperature controller.
  10. Shave the inguinal areas, disinfect the surgical area at least three times with iodine and alcohol (see Table of Materials), and cover the area with a sterile surgical drape.
  11. Apply eye ointment to both eyes and administer 5 mg/kg carprofen subcutaneously before surgery.
  12. Open the sterile instrument package for surgery. Make a 1 cm skin incision with surgical scissors to access the femoral arteries on both sides. Dissect and ligate the distal femoral artery with a single strand of 4-0 silk suture (see Table of Materials), and apply one drop of lidocaine.
  13. Apply an aneurysm clip at the proximal femoral artery and make a small cut on the artery distal to the clip. Insert a polyethylene 10 (PE-10, see Table of Materials) catheter into the left and the right femoral arteries.
    NOTE: The left arterial line is used for blood pressure monitoring, while the right one is used for blood withdrawal and resuscitation mixture infusion.
  14. Inject 50 µL of 1:10 heparinized saline into each arterial line to prevent clotting in the line.
  15. Turn the mouse to the prone position, and mount it on a stereotaxic head frame.
  16. Connect three needle electrodes (red, green, and black) to the left arm, left leg, and right arm for electrocardiogram (ECG, see Table of Materials) monitoring.
  17. Glue a flexible plastic fiber probe onto the intact temporal skull through a 0.5 cm skin incision for cerebral blood flow monitoring. This step is optional.
  18. Shave the top of the head, disinfect the surgical area at least three times with iodine and alcohol, and cover the area with a sterile surgical drapel.
  19. Cut a 2.5 cm midline skin incision, and use four small retractors to expose the entire skull surface for brain imaging.
  20. Place a monitoring imager (e.g., a laser speckle contrast imager, see Table of Materials) above the head.
    NOTE: A few drops of saline can be added to the skull surface to facilitate laser speckle contrast imaging.

2. Induction of cardiac arrest

  1. Fill a 1 mL plastic syringe with 26 µL of the resuscitation cocktail stock solution.
    NOTE: Each milliliter of this solution contains 400 µL of 1 mg/mL epinephrine, 500 µL of 8.4% sodium bicarbonate, 50 µL of 1,000 U/mL heparin, and 50 µL of 0.9% sodium chloride (see Table of Materials).
  2. Wait until the body temperature reaches 37 °C. Adjust the oxygen meter to 100% to oxygenate the blood for 2 min.
  3. Withdraw the oxygenated arterial blood up to 200 µL via the right femoral artery into the prepared plastic syringe containing 26 µL of resuscitation cocktail stock solution.
  4. Switch off the oxygen, and increase the nitrogen to 100% to induce anoxia.
    NOTE: After approximately 45 s, the heart will fail to function, and the heart rate will rapidly decrease, indicating the onset of CA. After about 2 min of oxygen deprivation, the ECG monitoring will indicate an asystole, and there will be no measurable systemic blood pressure and negligible cerebral blood flow.
  5. Turn off the ventilator, isoflurane vaporizer, temperature controller, and nitrogen flowmeter. Adjust the oxygen to 100% in preparation for resuscitation.

3. Resuscitation procedure

  1. Turn the ventilator on at 8 min after CA onset.
  2. Immediately start to infuse the withdrawn oxygenated blood mixed with the resuscitation cocktail into the blood circulation via the right femoral artery in 1 min.
    NOTE: The infusion leads to a gradual increase in the heart rate and the restoration of blood perfusion; eventually, the return of spontaneous circulation (ROSC) is achieved.

4. Post-CA recovery

  1. Place the mouse in the supine position after removing it from the stereotaxic frame, and remove the PE-10 catheters from the femoral arteries.
  2. Apply 0.25% bupivacaine to the skin incision, and suture the skin incisions using a 6-0 nylon suture (see Table of Materials). Apply antibiotic ointment to the surface of the skin incision.
  3. Disconnect the mouse ventilator when spontaneous respiration is restored.
  4. Transfer the mouse to a recovery chamber with a controlled temperature of 32 °C.
  5. After 2 h of recovery, extubate the mouse, and return to the home cage. Inject 0.5 mL of normal saline subcutaneously to prevent dehydration.

Results

To induce CA, the mouse was anesthetized with 1.5% isoflurane and ventilated with 100% nitrogen. This condition led to severe bradycardia in 45 s (Figure 1). Following 2 min of anoxia, the heart rate dramatically reduced (Figure 2), the blood pressure decreased below 20 mmHg, and the cerebral blood flow ceased completely (Figure 1). As the isoflurane was turned off, the body temperature was no longer managed and slowly dropped ...

Discussion

In experimental CA studies, asphyxia, potassium chloride injections, or electrical current-derived ventricular fibrillation have been used to induce CA16,17,18,19,20,21,22,23. Normally, CPR is required for resuscitation in these CA models, especially in mic...

Disclosures

The authors have no conflicts of interest.

Acknowledgements

The authors thank Kathy Gage for her editorial support. This study was supported by funds from the Department of Anesthesiology (Duke University Medical Center), American Heart Association grant (18CSA34080277), and National Institutes of Health (NIH) grants (NS099590, HL157354, NS117973, and NS127163).

Materials

NameCompanyCatalog NumberComments
AdrenalinPar PharmaceuticalNDC 42023-159-01
Alcohol swabsBD326895
Animal Bio AmpADInstrumentsFE232
BP transducerADInstrumentsMLT0699
Bridge AmpADInstrumentsFE117
Heparin sodium injection, USPFresenius KabiNDC 63323-540-05
IsofluraneCovetrusNDC 11695-6777-2
Laser Doppler perfusion monitorMoor InstrumentsmoorVMS-LDF1
Laser speckle imaging systemRWDRFLSI III
Lubricant eye ointmentBausch + Lomb339081
Micro clipRobozRS-5431
Mouse rectal probePhysitempRET-3
Needle electrodeADInstrumentsMLA121329 Ga, 1.5 mm socket
NitrogenAirgasUN1066
Optic plastic fibreMoor InstrumentsPOF500
OtoscopeWelchallyn7282.5 mm Speculum
OxygenAirgasUN1072
PE-10 tubingBD427401Polyethylene tubing
Povidone-iodineCVS955338
PowerLab 8/35ADInstruments
Rimadyl (carprofen)Zoetis6100701Injectable 50 mg/ml
Small animal ventilatorKent ScientificRoVent Jr.
Temperature controllerPhysitempTCAT-2DF
Triple antibioric & pain reliefCVSNDC 59770-823-56
VaporizerRWDR583S
0.25% bupivacaineHospiraNDC 0409-1159-18
0.9% sodium chrorideICU MedicalNDC 0990-7983-03
1 mL plastic syringeBD309659
4-0 silk sutureLookSP116Black braided silk
6-0 nylon sutureEthilon1698G
8.4% sodium bicarbonate Inj., USPHospiraNDC 0409-6625-02
20 G IV catheterBD38153420GA 1.6 IN
30 G PrecisionGlide needleBD30510630 G X 1/2

References

  1. Smith, A., Masters, S., Ball, S., Finn, J. The incidence and outcomes of out-of-hospital cardiac arrest in metropolitan versus rural locations: A systematic review and meta-analysis. Resuscitation. 185, 109655 (2022).
  2. Amacher, S. A., et al. Predicting neurological outcome in adult patients with cardiac arrest: systematic review and meta-analysis of prediction model performance. Critical Care. 26 (1), 382 (2022).
  3. Matsuyama, T., Ohta, B., Kiyohara, K., Kitamura, T. Intra-arrest partial carbon dioxide level and favorable neurological outcome after out-of-hospital cardiac arrest: A nationwide multicenter observational study in Japan (the JAAM-OHCA registry). European Heart Journal of Acute Cardiovascular Care. 12 (1), 14-21 (2023).
  4. Takahagi, M., Sawano, H., Moriyama, T. Long-term neurological outcome of extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest patients with nonshockable rhythms: A single-center, consecutive, retrospective observational study. The Journal of Emergency Medicine. 63 (3), 367-375 (2022).
  5. Mork, S. R., Botker, M. T., Christensen, S., Tang, M., Terkelsen, C. J. Survival and neurological outcome after out-of-hospital cardiac arrest treated with and without mechanical circulatory support. Resuscition Plus. 10, 100230 (2022).
  6. Koenig, M. A., Kaplan, P. W., Thakor, N. V. Clinical neurophysiologic monitoring and brain injury from cardiac arrest. Neurologic Clinics. 24 (1), 89-106 (2006).
  7. Cavazzoni, E., Schibler, A. Monitoring of brain tissue oxygen tension and use of vasopressin after cardiac arrest in a child with catecholamine-induced cardiac arrhythmia. Critical Care & Resuscitation. 10 (4), 316-319 (2008).
  8. Topjian, A. A., et al. Multimodal monitoring including early EEG improves stratification of brain injury severity after pediatric cardiac arrest. Resuscitation. 167, 282-288 (2021).
  9. Beekman, R., et al. Bedside monitoring of hypoxic ischemic brain injury using low-field, portable brain magnetic resonance imaging after cardiac arrest. Resuscitation. 176, 150-158 (2022).
  10. Sinha, N., Parnia, S. Monitoring the brain after cardiac arrest: A new era. Current Neurology Neuroscience Report. 17 (8), 62 (2017).
  11. Reis, C., et al. Pathophysiology and the monitoring methods for cardiac arrest associated brain injury. International Journal of Molecular Sciences. 18 (1), 129 (2017).
  12. Zhou, H., Lin, C., Liu, J., Wang, X. Continuous monitoring of brain perfusion by cerebral oximetry after spontaneous return of circulation in cardiac arrest: A case report. BMC Neurology. 22 (1), 365 (2022).
  13. Takegawa, R., et al. Real-time brain monitoring by near-infrared spectroscopy predicts neurological outcome after cardiac arrest and resuscitation in rats: A proof of concept study of a novel prognostic measure after cardiac arrest. Journal Clinical Medicine. 11 (1), 131 (2021).
  14. Zhang, C., et al. Invasion of peripheral immune cells into brain parenchyma after cardiac arrest and resuscitation. Aging and Disease. 9 (3), 412-425 (2018).
  15. Duan, W., et al. Cervical vagus nerve stimulation improves neurologic outcome after cardiac arrest in mice by attenuating oxidative stress and excessive autophagy. Neuromodulation. 25 (3), 414-423 (2022).
  16. Liu, H., et al. Novel modification of potassium chloride induced cardiac arrest model for aged mice. Aging and Disease. 9 (1), 31-39 (2018).
  17. Shen, Y., et al. Aging is associated with impaired activation of protein homeostasis-related pathways after cardiac arrest in mice. Journal of American Heart Association. 7 (17), e009634 (2018).
  18. Wang, P., et al. Manganese porphyrin promotes post cardiac arrest recovery in mice and rats. Biology. 11 (7), 957 (2022).
  19. Wang, W., et al. Development and evaluation of a novel mouse model of asphyxial cardiac arrest revealed severely impaired lymphopoiesis after resuscitation. Journal of American Heart Association. 10 (11), e019142 (2021).
  20. Li, R., et al. Activation of the XBP1s/O-GlcNAcylation pathway improves functional outcome after cardiac arrest and resuscitation in young and aged mice. Shock. 56 (5), 755-761 (2021).
  21. Shen, Y., et al. Activation of the ATF6 (activating transcription factor 6) signaling pathway in neurons improves outcome after cardiac arrest in mice. Journal American Heart Association. 10 (12), e020216 (2021).
  22. Jiang, M., et al. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation. Journal of Neuroinflammation. 17 (1), 256 (2020).
  23. Zhao, Q., et al. Cardiac arrest and resuscitation activates the hypothalamic-pituitary-adrenal axis and results in severe immunosuppression. Journal of Cerebral Blood Flow & Metabolism. 41 (5), 1091-1102 (2021).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Mouse Cardiac Arrest ModelBrain ImagingBrain Physiology MonitoringIschemiaResuscitationHypoxic ischemic Brain InjuryCerebral Blood FlowMicrocirculatory Blood FlowEpinephrine AdministrationDynamic AlterationsVascular ResponsesBrain Tissue OxygenationExperimental ResearchChest Compression CPRAnimal MovementImaging Modalities

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved